TSX-V:AVCR - CA0545211090 - Common Stock
The current stock price of AVCR.CA is 0.07 CAD. In the past month the price decreased by -12.5%. In the past year, price decreased by -70.83%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VHI.CA | VITALHUB CORP | 122 | 764.94M | ||
KSI.CA | KNEAT.COM INC | N/A | 510.26M | ||
NURS.CA | HYDREIGHT TECHNOLOGIES INC | N/A | 153.68M | ||
KDA.CA | KDA GROUP INC | N/A | 52.45M | ||
ADK.CA | DIAGNOS INC | N/A | 26.48M | ||
CHS.CA | COMPREHENSIVE HEALTHCARE SYS | N/A | 10.23M | ||
KOVO.CA | KOVO+ HOLDINGS INC | N/A | 7.96M | ||
EKG.CA | CARDIOCOMM SOLUTIONS INC | N/A | 1.97M |
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
AVRICORE HEALTH INC
1120 - 789 West Pender Street
Vancouver BRITISH COLUMBIA V7X 1H7 CA
CEO: Hector Bremner
Employees: 25
Phone: 16047738943
The current stock price of AVCR.CA is 0.07 CAD. The price decreased by -12.5% in the last trading session.
The exchange symbol of AVRICORE HEALTH INC is AVCR and it is listed on the TSX Venture Exchange exchange.
AVCR.CA stock is listed on the TSX Venture Exchange exchange.
AVRICORE HEALTH INC (AVCR.CA) has a market capitalization of 7.09M CAD. This makes AVCR.CA a Nano Cap stock.
AVRICORE HEALTH INC (AVCR.CA) currently has 25 employees.
AVRICORE HEALTH INC (AVCR.CA) has a support level at 0.06 and a resistance level at 0.07. Check the full technical report for a detailed analysis of AVCR.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AVCR.CA does not pay a dividend.
AVRICORE HEALTH INC (AVCR.CA) will report earnings on 2025-11-27.
AVRICORE HEALTH INC (AVCR.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
ChartMill assigns a technical rating of 4 / 10 to AVCR.CA. When comparing the yearly performance of all stocks, AVCR.CA is a bad performer in the overall market: 91.03% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to AVCR.CA. While AVCR.CA has a great health rating, there are worries on its profitability.
Over the last trailing twelve months AVCR.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -194.29% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -42.76% | ||
ROE | -46.86% | ||
Debt/Equity | 0 |